Evidence suggests that everolimus is an effective add-on treatment for epilepsy in adult TSC patients, surprisingly without any age limit to individual benefit.
Several multilateral organizations, such as the United Nations, UNESCO and the World Health Organization, have recognized the importance of engaging youth in the global agenda.
Only patients have full and first-hand knowledge of subjective symptoms but an understanding of these symptoms and an adequate response to them requires expert assistance.
Traumatic brain injuries are a major risk factor for certain types of dementia. This research discovered one important way they are linked—namely, post-injury seizures.
Epilepsy has not stopped during this pandemic, and with your help we will continue to drive science forward. See what's new in this month's update.
In this review, we discuss the role of Big Data in the development of clinical decision support systems for epilepsy care, prognostication, and discovery.
Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted.
A Neonatal Seizures Task Force was established by the International League Against Epilepsy (ILAE) to develop a modification of the 2017 ILAE Classification of Seizures and Epilepsies, relevant to neonates.
This study showed that seizure is rarely (< 1%) a presenting manifestation of COVID-19, and it is reasonable to assume that seizures have happened due to the infection and its neurological consequences, at least in some patients.
